These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 22341583

  • 21. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.
    Touma Z, Urowitz MB, Gladman DD.
    Expert Opin Biol Ther; 2013 May; 13(5):723-37. PubMed ID: 23339281
    [Abstract] [Full Text] [Related]

  • 22. Conventional therapy of psoriatic arthritis: evidence-based review.
    McHugh NJ, Soriano ER.
    Reumatismo; 2007 May; 59 Suppl 1():81-4. PubMed ID: 17828352
    [Abstract] [Full Text] [Related]

  • 23. [The management of systemic lupus erythematosus with biological therapies].
    Malaise O, von Frenckell C, André B, Malaise MG.
    Rev Med Suisse; 2013 Aug 28; 9(395):1507-11. PubMed ID: 24024419
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
    Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR.
    Rheumatology (Oxford); 2002 Aug 28; 41(8):876-82. PubMed ID: 12154204
    [Abstract] [Full Text] [Related]

  • 32. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
    Furie R, Toder K, Zapantis E.
    Semin Nephrol; 2015 Sep 28; 35(5):509-20. PubMed ID: 26573553
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. When biologics should be used in systemic lupus erythematosus?
    Gottenberg JE, Lorenzo N, Sordet C, Theulin A, Chatelus E, Sibilia J.
    Presse Med; 2014 Jun 28; 43(6 Pt 2):e181-5. PubMed ID: 24933678
    [Abstract] [Full Text] [Related]

  • 35. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct 28; 18(103):198-201. PubMed ID: 19882783
    [Abstract] [Full Text] [Related]

  • 36. Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?
    Haroon M, Ryan JG, Harney S.
    Clin Rheumatol; 2011 Aug 28; 30(8):1095-8. PubMed ID: 21380931
    [Abstract] [Full Text] [Related]

  • 37. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R.
    Autoimmun Rev; 2010 Dec 28; 10(2):108-11. PubMed ID: 20804861
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.